NO954321D0 - 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer - Google Patents
4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorerInfo
- Publication number
- NO954321D0 NO954321D0 NO954321A NO954321A NO954321D0 NO 954321 D0 NO954321 D0 NO 954321D0 NO 954321 A NO954321 A NO 954321A NO 954321 A NO954321 A NO 954321A NO 954321 D0 NO954321 D0 NO 954321D0
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- hydroxy
- tetrahydropyrans
- tetrahydrofurans
- lipoxygenase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP93401120 | 1993-04-29 | ||
| EP93401991 | 1993-08-02 | ||
| EP94400190 | 1994-01-28 | ||
| PCT/EP1994/001277 WO1994025453A1 (en) | 1993-04-29 | 1994-04-25 | 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO954321D0 true NO954321D0 (no) | 1995-10-27 |
| NO954321L NO954321L (no) | 1995-10-27 |
| NO309191B1 NO309191B1 (no) | 2000-12-27 |
Family
ID=27235558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO954321A NO309191B1 (no) | 1993-04-29 | 1995-10-27 | Eterderivater, anvendelse derav og farmasöytisk blanding |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5478842A (no) |
| EP (1) | EP0623614B1 (no) |
| JP (1) | JP3553127B2 (no) |
| KR (1) | KR100358464B1 (no) |
| CN (1) | CN1052002C (no) |
| AP (1) | AP9400632A0 (no) |
| AT (1) | ATE163417T1 (no) |
| AU (1) | AU681886B2 (no) |
| CA (1) | CA2121199C (no) |
| CZ (1) | CZ280695A3 (no) |
| DE (1) | DE69408593T2 (no) |
| DK (1) | DK0623614T3 (no) |
| ES (1) | ES2112483T3 (no) |
| FI (2) | FI109123B (no) |
| GB (1) | GB9408001D0 (no) |
| HK (1) | HK1004777A1 (no) |
| HU (1) | HU9502968D0 (no) |
| IL (1) | IL109254A (no) |
| NO (1) | NO309191B1 (no) |
| NZ (1) | NZ266139A (no) |
| PL (1) | PL311300A1 (no) |
| SK (1) | SK134995A3 (no) |
| TW (1) | TW252978B (no) |
| WO (1) | WO1994025453A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3990972B2 (ja) * | 2001-11-20 | 2007-10-17 | 有限会社 キック | 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具 |
| SE0104274D0 (sv) * | 2001-12-17 | 2001-12-17 | Astrazeneca Ab | Novel process |
| DE102004002557A1 (de) * | 2004-01-17 | 2005-08-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen |
| US8158362B2 (en) | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
| EP1978966A4 (en) | 2006-01-23 | 2010-11-10 | Amira Pharmaceuticals Inc | TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE |
| WO2008067566A1 (en) | 2006-11-30 | 2008-06-05 | Amira Pharmaceuticals, Inc. | Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators |
| US10793515B2 (en) * | 2008-03-19 | 2020-10-06 | Aurimmed Pharma, Inc. | Compounds advantageous in the treatment of central nervous system diseases and disorders |
| EP3791880A1 (en) | 2009-04-29 | 2021-03-17 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical compositions comprising epa |
| CN106456624B (zh) | 2014-02-04 | 2020-05-22 | 生物制药合伙公司 | Flap抑制剂的降低中枢神经***内的神经炎症介导的损伤的应用 |
| ME03663B (me) | 2015-05-04 | 2020-07-20 | Astrazeneca Ab | Derivati rirazola korisni kao inhibitori proteina koji aktivira 5-lipoksigenazu (flap) |
| SG11201903414SA (en) | 2016-10-28 | 2019-05-30 | Astrazeneca Ab | Crystalline form of (1r,2r)-2-[4-(3-methy1-1h-pyrazol-5-yl)benzoyl]-n-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4567184A (en) * | 1982-12-01 | 1986-01-28 | Usv Pharmaceutical Corporation | Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies |
| US4794188A (en) * | 1982-12-01 | 1988-12-27 | Usv Pharmaceutical Corporation | Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity |
| US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
| US4728668A (en) * | 1985-04-16 | 1988-03-01 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4631287A (en) * | 1985-04-16 | 1986-12-23 | Usv Pharmaceutical Corp. | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4725619A (en) * | 1985-04-16 | 1988-02-16 | Usv Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4868193A (en) * | 1986-09-24 | 1989-09-19 | Rorer Pharmaceutical Corporation | Styryl tetrazoles and anti-allergic use thereof |
| US5234950A (en) * | 1988-12-23 | 1993-08-10 | Imperial Chemical Industries Plc | Tetrahydrofuran derivatives |
| GB8926981D0 (en) * | 1988-12-23 | 1990-01-17 | Ici Plc | Heterocyclic derivatives |
| IE70521B1 (en) * | 1989-02-28 | 1996-12-11 | Zeneca Pharma Sa | Heterocycles with inhibitory activity of 5-lipoxygenase |
| US5134148A (en) * | 1989-02-28 | 1992-07-28 | Imperial Chemical Industries Plc | Heterocycles for use as inhibitors of leukotrienes |
| US5202326A (en) * | 1989-02-28 | 1993-04-13 | Imperial Chemical Industries Plc | Heterocyclic ethers |
| US5236919A (en) * | 1989-02-28 | 1993-08-17 | Imperial Chemical Industries Plc | Quinoxalinyl derivatives suitable for use in leukotriene mediated disease |
| IE64358B1 (en) * | 1989-07-18 | 1995-07-26 | Ici Plc | Diaryl ether heterocycles |
| GB9018134D0 (en) * | 1989-09-29 | 1990-10-03 | Ici Plc | Heterocyclic derivatives |
| US5088927A (en) * | 1990-06-18 | 1992-02-18 | Lee Howard G | Radio opaque plastics and process of making |
| IE911853A1 (en) * | 1990-06-21 | 1992-01-01 | Ici Plc | Heterocyclene derivatives |
| IE911919A1 (en) * | 1990-06-21 | 1992-01-01 | Zeneca Ltd | Bicyclic heterocyclic compounds |
| GB9113137D0 (en) * | 1990-07-13 | 1991-08-07 | Ici Plc | Thioxo heterocycles |
| IE913866A1 (en) * | 1990-11-28 | 1992-06-03 | Ici Plc | Aryl derivatives |
| US5272173A (en) * | 1990-11-28 | 1993-12-21 | Imperial Chemical Industries Plc | 5-lipoxygenase inhibitors |
| EP0501578A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis |
| EP0501579A1 (en) * | 1991-02-28 | 1992-09-02 | Merck Frosst Canada Inc. | Naphthalene lactones as inhibitors of leukotriene biosynthesis |
| US5308852A (en) * | 1992-06-29 | 1994-05-03 | Merck Frosst Canada, Inc. | Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
-
1994
- 1994-04-07 AP APAP/P/1994/000632A patent/AP9400632A0/en unknown
- 1994-04-07 IL IL10925494A patent/IL109254A/en not_active IP Right Cessation
- 1994-04-13 CA CA002121199A patent/CA2121199C/en not_active Expired - Fee Related
- 1994-04-22 GB GB9408001A patent/GB9408001D0/en active Pending
- 1994-04-25 SK SK1349-95A patent/SK134995A3/sk unknown
- 1994-04-25 AU AU67212/94A patent/AU681886B2/en not_active Ceased
- 1994-04-25 WO PCT/EP1994/001277 patent/WO1994025453A1/en active IP Right Grant
- 1994-04-25 CN CN94191925A patent/CN1052002C/zh not_active Expired - Fee Related
- 1994-04-25 NZ NZ266139A patent/NZ266139A/xx not_active IP Right Cessation
- 1994-04-25 KR KR1019950704723A patent/KR100358464B1/ko not_active IP Right Cessation
- 1994-04-25 CZ CZ952806A patent/CZ280695A3/cs unknown
- 1994-04-25 HU HU9502968A patent/HU9502968D0/hu unknown
- 1994-04-25 PL PL94311300A patent/PL311300A1/xx unknown
- 1994-04-26 EP EP94303012A patent/EP0623614B1/en not_active Expired - Lifetime
- 1994-04-26 DE DE69408593T patent/DE69408593T2/de not_active Expired - Fee Related
- 1994-04-26 ES ES94303012T patent/ES2112483T3/es not_active Expired - Lifetime
- 1994-04-26 JP JP08882694A patent/JP3553127B2/ja not_active Expired - Fee Related
- 1994-04-26 AT AT94303012T patent/ATE163417T1/de not_active IP Right Cessation
- 1994-04-26 DK DK94303012T patent/DK0623614T3/da active
- 1994-04-28 US US08/234,148 patent/US5478842A/en not_active Expired - Lifetime
- 1994-04-30 TW TW083103922A patent/TW252978B/zh active
-
1995
- 1995-05-12 US US08/440,132 patent/US5512594A/en not_active Expired - Lifetime
- 1995-10-27 NO NO954321A patent/NO309191B1/no not_active IP Right Cessation
- 1995-10-27 FI FI955165A patent/FI109123B/fi active
-
1998
- 1998-05-05 HK HK98103836A patent/HK1004777A1/xx not_active IP Right Cessation
-
2002
- 2002-02-11 FI FI20020270A patent/FI20020270A/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0922697T3 (da) | Substituerede pyrazolylbenzensulfonamider og anvendelse deraf som cyclooxygenase II-inhibitorer | |
| NO942064D0 (no) | yminhibitorer | |
| FI962315A (fi) | Entsyymi-inhibiittorit | |
| NO961425D0 (no) | 1N-alkyl-N-arylpyrimidinaminer og derivater derav | |
| FI963597A0 (fi) | Isoprenyylitransferaasi-inhibiittoreita | |
| NO972930D0 (no) | Fibronectin-adhesjonsinhibitorer | |
| NO990296D0 (no) | HPPD-genet og inhibitorer | |
| FI972160A (fi) | Matriisimetalloproteaasi-inhibiittorit | |
| DK0944590T3 (da) | Aminoguanidiner og alkoxyguanidiner som proteaseinhibitorer | |
| NO943763D0 (no) | 4-arylamino-benzopyraner og beslektede forbindelser | |
| NO942247D0 (no) | Korrosjonsinhibitor og anvendelse derav | |
| NO954321L (no) | 4-aryl-4-hydroksy-tetrahydropyraner og 3-aryl-3-hydroksy-tetrahydrofuraner som 5-lipoksygenase-inhibitorer | |
| DE69421131D1 (de) | Schraubenschlüssel | |
| DE69419620D1 (de) | Fluorierungsverfahren | |
| DE69404666T2 (de) | Schraubenschlüssel | |
| DE69431454D1 (de) | Amylase Inhibitoren | |
| DE9309682U1 (de) | Schrauber | |
| NO930418D0 (no) | Innstikkbar helletut | |
| DK0790981T3 (da) | Aryloxycycloalkenyl og aryloxyiminocycloalkenylhydroxyurinstoffer som 5-lipoxygenaseinhibitorer | |
| KR950008806U (ko) | 빠렛드 | |
| DE69406031T2 (de) | Schraubenzieher | |
| KR950016614U (ko) | 젓가락겸용 숟가락 | |
| BR7301860U (pt) | Cotonete | |
| NO934392D0 (no) | Rullgardin og beslag for rullgardin | |
| SE9303753D0 (sv) | Skiftnyckel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |